Lv212
186 积分 2024-05-29 加入
Emerging biologic therapies for systemic lupus erythematosus
16天前
已完结
Efficacy and safety of belimumab in systemic lupus erythematosus patients with severe lupus nephritis requiring renal replacement therapy
16天前
已完结
Mortality and adverse events of special interest with intravenous belimumab for adults with active, autoantibody-positive systemic lupus erythematosus (BASE): a multicentre, double-blind, randomised, placebo-controlled, phase 4 trial
16天前
已完结
Efficacy and safety of the CD40 ligand inhibitor dapirolizumab pegol in systemic lupus erythematosus (PHOENYCS GO): a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Dapirolizumab pegol improves SLE disease activity in phase III trial
1个月前
已完结
皖公网安备34019202002308
